Compare Procter & Gamble Health with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs SUVEN LIFESCIENCES - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH SUVEN LIFESCIENCES PROCTER & GAMBLE HEALTH/
SUVEN LIFESCIENCES
 
P/E (TTM) x 53.0 20.4 259.4% View Chart
P/BV x 4.8 4.1 115.8% View Chart
Dividend Yield % 9.9 0.5 1,941.3%  

Financials

 PROCTER & GAMBLE HEALTH   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
SUVEN LIFESCIENCES
Mar-19
PROCTER & GAMBLE HEALTH/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs3,549338 1,050.9%   
Low Rs1,301169 768.2%   
Sales per share (Unadj.) Rs511.452.1 981.1%  
Earnings per share (Unadj.) Rs61.36.8 897.3%  
Cash flow per share (Unadj.) Rs74.08.6 863.6%  
Dividends per share (Unadj.) Rs440.001.50 29,333.3%  
Dividend yield (eoy) %18.10.6 3,066.8%  
Book value per share (Unadj.) Rs927.865.3 1,421.0%  
Shares outstanding (eoy) m16.60127.28 13.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.74.9 97.5%   
Avg P/E ratio x39.637.1 106.6%  
P/CF ratio (eoy) x32.829.6 110.8%  
Price / Book Value ratio x2.63.9 67.3%  
Dividend payout %717.922.0 3,269.2%   
Avg Mkt Cap Rs m40,25732,272 124.7%   
No. of employees `0001.11.1 104.8%   
Total wages/salary Rs m1,313661 198.5%   
Avg. sales/employee Rs Th7,486.76,132.2 122.1%   
Avg. wages/employee Rs Th1,157.6611.1 189.4%   
Avg. net profit/employee Rs Th897.2803.5 111.7%   
INCOME DATA
Net Sales Rs m8,4906,635 128.0%  
Other income Rs m244242 100.7%   
Total revenues Rs m8,7346,877 127.0%   
Gross profit Rs m1,4821,604 92.4%  
Depreciation Rs m211221 95.4%   
Interest Rs m038 0.0%   
Profit before tax Rs m1,5141,587 95.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m563718 78.3%   
Profit after tax Rs m1,017869 117.0%  
Gross profit margin %17.524.2 72.2%  
Effective tax rate %37.145.2 82.1%   
Net profit margin %12.013.1 91.5%  
BALANCE SHEET DATA
Current assets Rs m15,3436,232 246.2%   
Current liabilities Rs m1,9601,490 131.5%   
Net working cap to sales %157.671.5 220.6%  
Current ratio x7.84.2 187.1%  
Inventory Days Days4986 56.4%  
Debtors Days Days2883 34.4%  
Net fixed assets Rs m1,2094,043 29.9%   
Share capital Rs m166127 130.4%   
"Free" reserves Rs m15,2358,183 186.2%   
Net worth Rs m15,4018,310 185.3%   
Long term debt Rs m018 0.0%   
Total assets Rs m17,59510,389 169.4%  
Interest coverage xNM43.1-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.6 75.6%   
Return on assets %5.88.7 66.2%  
Return on equity %6.610.5 63.1%  
Return on capital %10.319.5 52.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,6365,622 29.1%   
Fx outflow Rs m4,3681,799 242.8%   
Net fx Rs m-2,7323,822 -71.5%   
CASH FLOW
From Operations Rs m-1,304356 -366.8%  
From Investments Rs m12,697-279 -4,557.5%  
From Financial Activity Rs m-301-225 133.5%  
Net Cashflow Rs m11,093-148 -7,485.1%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.0 -  
FIIs % 1.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 36.5 79.7%  
Shareholders   28,591 37,287 76.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   IPCA LABS  NOVARTIS  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare PROCTER & GAMBLE HEALTH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

ABBOTT INDIA at All Time High; BSE HEALTHCARE Index Up 0.4% (Market Updates)

Sep 16, 2019 | Updated on Sep 16, 2019

ABBOTT INDIA share price has hit an all time high at Rs 10,015 (up 1.5%). The BSE HEALTHCARE Index is up by 0.4%. Among the top gainers in the BSE HEALTHCARE Index today are ABBOTT INDIA (up 1.5%) and PROCTER & GAMBLE HEALTH (up 1.2%). The top losers include NATCO PHARMA (down 0.2%) and BIOCON (down 0.2%).

SUVEN LIFESCIENCES Surges by 5%; BSE HEALTHCARE Index Up 0.5% (Market Updates)

Sep 16, 2019 | Updated on Sep 16, 2019

SUVEN LIFESCIENCES share price has surged by 5% and its current market price is Rs 294. The BSE HEALTHCARE is up by 0.5%. The top gainers in the BSE HEALTHCARE Index are SUVEN LIFESCIENCES (up 5.2%) and WOCKHARDT (up 7.4%). The top losers are AJANTA PHARMA and PIRAMAL ENTERPRISES (down 0.2%).

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Sep 16, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 5-YR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS